HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ralf Köhler Selected Research

Hypoxia (Hypoxemia)

1/2014Pulmonary hypertension in wild type mice and animals with genetic deficit in KCa2.3 and KCa3.1 channels.
10/2013Alterations of N-3 polyunsaturated fatty acid-activated K2P channels in hypoxia-induced pulmonary hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ralf Köhler Research Topics

Disease

8Hypertension (High Blood Pressure)
12/2015 - 08/2001
6Neoplasms (Cancer)
01/2021 - 01/2013
2Ulcerative Colitis
12/2020 - 11/2014
2Hyperplasia
01/2020 - 09/2003
2Melanoma (Melanoma, Malignant)
01/2020 - 01/2018
2Neuroinflammatory Diseases
01/2017 - 12/2016
2Cardiovascular Diseases (Cardiovascular Disease)
12/2015 - 06/2009
2Fibrosis (Cirrhosis)
04/2015 - 08/2009
2Inflammation (Inflammations)
11/2014 - 01/2013
2Hypoxia (Hypoxemia)
01/2014 - 10/2013
1Kidney Diseases (Kidney Disease)
01/2021
1Human Influenza (Influenza)
01/2021
1Skin Diseases (Skin Disease)
01/2020
1Wolman Disease (Wolman's Disease)
05/2018
1Lysosomal Storage Diseases (Lysosomal Storage Disease)
05/2018
1Fabry Disease (Fabry's Disease)
01/2017
1Ischemia
12/2016
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
12/2016
1Infarction (Infarctions)
12/2016
1Stroke (Strokes)
12/2016
1Hemorrhage
02/2016
1Scott Syndrome
02/2016
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2016
1Aortic Aneurysm (Aneurysm, Aortic)
09/2015
1Shock
09/2015
1Bradycardia
02/2015
1Oxyphilic Adenoma (Oncocytoma)
01/2015
1Neoplasm Metastasis (Metastasis)
01/2015
1Renal Cell Carcinoma (Grawitz Tumor)
01/2015
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2014
1Pulmonary Hypertension
10/2013
1Epilepsy (Aura)
02/2013
1Ataxia (Dyssynergia)
02/2013
1Hyperaldosteronism (Conn Syndrome)
05/2010
1Dehydration (Water Stress)
06/2009

Drug/Important Bio-Agent (IBA)

5TRAM 34IBA
12/2016 - 09/2003
4Ion Channels (Ion Channel)IBA
01/2020 - 08/2001
4Proteins (Proteins, Gene)FDA Link
02/2016 - 11/2014
3Pharmaceutical PreparationsIBA
12/2020 - 08/2010
3CalciumIBA
01/2018 - 09/2015
3Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2017 - 10/2013
2CytokinesIBA
01/2020 - 11/2014
2Protein Isoforms (Isoforms)IBA
01/2020 - 01/2017
2Potassium Channels (Potassium Channel)IBA
12/2016 - 08/2009
2CollagenIBA
02/2016 - 09/2003
2Angiotensin IIIBA
09/2015 - 02/2009
2Messenger RNA (mRNA)IBA
01/2015 - 11/2014
2Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA
01/2015 - 09/2003
2Acetylcholine (Acetylcholine Chloride)FDA Link
01/2014 - 07/2008
2ApaminIBA
01/2014 - 02/2013
2naphtho(1,2-d)thiazol-2-ylamineIBA
09/2013 - 02/2009
2endothelium-dependent hyperpolarization factor (EDHF)IBA
06/2009 - 06/2005
1LigandsIBA
01/2021
1Granzymes (Granzyme)IBA
01/2021
1EpitopesIBA
01/2021
1AntigensIBA
01/2021
1Dextrans (Dextran)FDA Link
12/2020
1SodiumIBA
12/2020
1Sulfasalazine (Azulfidine)FDA LinkGeneric
12/2020
1Enzyme Inhibitors (Inhibitors, Enzyme)IBA
01/2020
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
01/2020
1Interleukin-6 (Interleukin 6)IBA
01/2020
1senicapocIBA
01/2020
1Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
01/2020
1PyrrolesIBA
01/2020
1CholesterolIBA
05/2018
1Sterol Esterase (Hormone-Sensitive Lipase)IBA
05/2018
1Protein Kinases (Protein Kinase)IBA
01/2017
1Biomarkers (Surrogate Marker)IBA
01/2017
1Casein Kinase II (Casein Kinase 2)IBA
01/2017
1NADPH Oxidases (NAD(P)H oxidase)IBA
01/2017
1alpha-Linolenic Acid (Linolenic Acid)IBA
01/2017
1Lysergic Acid Diethylamide (LSD)IBA
01/2017
1NAD (NADH)IBA
01/2017
1CalpainIBA
02/2016
1AnoctaminsIBA
02/2016
1PhosphatidylserinesIBA
02/2016
1Carbon Tetrachloride (Tetrachloromethane)IBA
01/2016
1TeaIBA
12/2015
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
09/2015
1N- (1- ((4- (2- (((2,4- dichlorophenyl)sulfonyl)amino)- 3- hydroxypropanoyl)- 1- piperazinyl)carbonyl)- 3- methylbutyl)- 1- benzothiophene- 2- carboxamideIBA
09/2015
1NADP (NADPH)IBA
09/2015
1ThymidineIBA
04/2015
1Benzoates (Benzoate)IBA
02/2015
1Kv1.3 Potassium ChannelIBA
11/2014
1Interleukin-17 (Interleukin 17)IBA
11/2014
1Charybdotoxin (ChTX)IBA
01/2014
1Hydroxyeicosatetraenoic Acids (HETE)IBA
01/2014
1Pentacyclic TriterpenesIBA
01/2014
1CytochromesIBA
01/2014
1HydrolasesIBA
01/2014
1AcidsIBA
01/2014
1ProstaglandinsIBA
08/2010
1Nitric Oxide Synthase (NO Synthase)IBA
08/2010
1Arginine (L-Arginine)FDA Link
08/2010
1Vasoconstrictor AgentsIBA
08/2010
1Soluble Guanylyl CyclaseIBA
08/2010
1Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA
05/2010

Therapy/Procedure

1Kidney Transplantation
01/2021
1Therapeutics
02/2013